EFFECT OF MACROPHAGES ON INTERLEUKIN-2 (IL-2)-INDUCED AND IL-4-INDUCED MURINE LYMPHOKINE-ACTIVATED KILLER ACTIVITY

被引:7
|
作者
TUNRU, IS [1 ]
SUZUKI, H [1 ]
YANO, S [1 ]
机构
[1] TOYAMA MED & PHARMACEUT UNIV, DEPT INTERNAL MED 1, 2630 SUGITANI, SUGITANI, TOYAMA 93001, JAPAN
关键词
D O I
10.1002/ijc.2910480415
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The enhancing effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer (LAK) activity was investigated in this study. Peritoneal macrophages significantly enhanced LAK activity generated from accessory cell-depleted splenic lymphocytes in both IL-2 and IL-4 cultures. This effect was dependent on the number of macrophages and was not replaced by a factor derived from macrophages or lymphocytes. Macrophages enhanced IL-2- and IL-4-induced LAK activity against both natural killer (NK)-sensitive (YAC-I, P388D1) and NK-resistant (P815) tumor cells. Negative selection of cells with antibodies and complement showed no differences in surface markers between IL-2 LAK effectors and IL-4 LAK effectors generated in the presence of macrophages. These results suggest that the same LAK effector subsets can be enhanced by macrophages in either IL-2 or IL-4 cultures.
引用
收藏
页码:568 / 573
页数:6
相关论文
共 50 条
  • [41] ADDITION OF INTERLEUKIN-2 INVITRO AUGMENTS DETECTION OF LYMPHOKINE-ACTIVATED KILLER ACTIVITY GENERATED INVIVO
    HANK, JA
    WEILHILLMAN, G
    SURFUS, JE
    SOSMAN, JA
    SONDEL, PM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (01) : 53 - 59
  • [42] SUCCESSFUL IMMUNOTHERAPY OF MURINE EXPERIMENTAL HEPATIC METASTASES WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2
    LAFRENIERE, R
    ROSENBERG, SA
    CANCER RESEARCH, 1985, 45 (08) : 3735 - 3741
  • [43] SYNERGISTIC INDUCTION OF LYMPHOKINE (IL-2)-ACTIVATED KILLER ACTIVITY BY IL-2 AND THE POLYSACCHARIDE LENTINAN, AND THERAPY OF SPONTANEOUS PULMONARY METASTASES
    YAMASAKI, K
    SONE, S
    YAMASHITA, T
    OGURA, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 29 (02) : 87 - 92
  • [44] THE ROLE OF EOSINOPHILS IN INTERLEUKIN-2/LYMPHOKINE-ACTIVATED KILLER (LAK) CELL THERAPY
    ISHIMITSU, T
    IWASAKI, K
    TORISU, M
    FASEB JOURNAL, 1992, 6 (04): : A1152 - A1152
  • [45] THE ROLE OF EOSINOPHILS IN INTERLEUKIN-2/LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY
    ISHIMITSU, T
    TORISU, M
    SURGERY, 1993, 113 (02) : 192 - 199
  • [46] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .3. EVIDENCE THAT IL-2 IS SUFFICIENT FOR DIRECT ACTIVATION OF PERIPHERAL-BLOOD LYMPHOCYTES INTO LYMPHOKINE-ACTIVATED KILLER CELLS
    GRIMM, EA
    ROBB, RJ
    ROTH, JA
    NECKERS, LM
    LACHMAN, LB
    WILSON, DJ
    ROSENBERG, SA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04): : 1356 - 1361
  • [47] THE HEMODYNAMIC-EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    GAYNOR, ER
    VITEK, L
    STICKLIN, L
    CREEKMORE, SP
    FERRARO, ME
    THOMAS, JX
    FISHER, SG
    FISHER, RI
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (12) : 953 - 958
  • [48] TREATMENT OF CANCER WITH LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 - REPLY
    ROSENBERG, SA
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (15): : 962 - 963
  • [49] THE NEUROPSYCHIATRIC EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    DENICOFF, KD
    RUBINOW, DR
    PAPA, MZ
    SIMPSON, C
    SEIPP, CA
    LOTZE, MT
    CHANG, AE
    ROSENSTEIN, D
    ROSENBERG, SA
    ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) : 293 - 300
  • [50] NOVEL INTERLEUKIN-2 (IL-2) RECEPTOR APPEARS TO MEDIATE IL-2-INDUCED ACTIVATION OF NATURAL-KILLER CELLS
    KEHRL, JH
    DUKOVICH, M
    WHALEN, G
    KATZ, P
    FAUCI, AS
    GREENE, WC
    JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (01): : 200 - 205